Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes
Status:
Not yet recruiting
Trial end date:
2027-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical efficacy of albumin paclitaxel combined with carelizumab and FLOT in
the neoadjuvant treatment of locally advanced gastric cancer with different immune types